Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2LDR

Solution structure of Helix-RING domain of Cbl-b in the Tyr363 phosphorylated form

2LDR の概要
エントリーDOI10.2210/pdb2ldr/pdb
NMR情報BMRB: 17680
分子名称E3 ubiquitin-protein ligase CBL-B, ZINC ION (2 entities in total)
機能のキーワードe3 ligase, ubiquitin, ring domain, ligase
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: Q13191
タンパク質・核酸の鎖数1
化学式量合計9395.29
構造登録者
Kumeta, H.,Kobashigawa, Y.,Inagaki, F. (登録日: 2011-06-01, 公開日: 2011-12-14, 最終更新日: 2024-11-20)
主引用文献Kobashigawa, Y.,Tomitaka, A.,Kumeta, H.,Noda, N.N.,Yamaguchi, M.,Inagaki, F.
Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b
Proc.Natl.Acad.Sci.USA, 108:20579-20584, 2011
Cited by
PubMed Abstract: Cbl-b is a RING-type E3 ubiquitin ligase that functions as a negative regulator of T-cell activation and growth factor receptor and nonreceptor-type tyrosine kinase signaling. Cbl-b dysfunction is related to autoimmune diseases and cancers in humans. However, the molecular mechanism regulating its E3 activity is largely unknown. NMR and small-angle X-ray scattering analyses revealed that the unphosphorylated N-terminal region of Cbl-b forms a compact structure by an intramolecular interaction, which masks the interaction surface of the RING domain with an E2 ubiquitin-conjugating enzyme. Phosphorylation of Y363, located in the helix-linker region between the tyrosine kinase binding and the RING domains, disrupts the interdomain interaction to expose the E2 binding surface of the RING domain. Structural analysis revealed that the phosphorylated helix-RING region forms a compact structure in solution. Moreover, the phosphate group of pY363 is located in the vicinity of the interaction surface with UbcH5B to increase affinity by reducing their electrostatic repulsion. Thus, the phosphorylation of Y363 regulates the E3 activity of Cbl-b by two mechanisms: one is to remove the masking of the RING domain from the tyrosine kinase binding domain and the other is to form a surface to enhance binding affinity to E2.
PubMed: 22158902
DOI: 10.1073/pnas.1110712108
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 2ldr
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon